Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceChange in ReceivablesChange in Working CapitalDeferred TaxesNet Debt Issuances and RepaymentsOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Beginning Cash Balance: 2023-2025

  • Zhengye Biotechnology Holding's Beginning Cash Balance was N/A to $6.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2024, which is 1224.53% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Beginning Cash Balance stood at $6.3 million for Q2 2025, which was up 147.37% from $2.5 million recorded in Q4 2024.
  • Over the past 5 years, Zhengye Biotechnology Holding's Beginning Cash Balance peaked at $6.3 million during Q2 2025, and registered a low of $2.1 million during Q4 2023.
  • Moreover, its 3-year median value for Beginning Cash Balance was $2.5 million (2024), whereas its average is $3.6 million.
  • Data for Zhengye Biotechnology Holding's Beginning Cash Balance shows a peak YoY rose of 21.76% (in 2024) over the last 5 years.
  • Over the past 3 years, Zhengye Biotechnology Holding's Beginning Cash Balance (Quarterly) stood at $2.1 million in 2023, then grew by 21.76% to $2.5 million in 2024, then reached $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q2 2025, $2.5 million for Q4 2024, and $2.1 million during Q4 2023.